One of the assets shelved by Eli Lilly is a gene therapy for dementia, which it obtained in its $1.04-billion acquisition of Prevail Therapeutics in late 2020.

Bio-inspired medical devices can gather more data than ever before, and HPC/quantum will massively speed up discovery rates; consumer self-testing will be slower.

By analyzing tissue from patients with Parkinson’s disease, and animal and cellular models of the disease, a research team from the Institut de Neurociències of the UAB has shown that the main immune ...

Biocomputing research is testing living neurons for computation as scientists look for energy-efficient alternatives to ...

Life Biosciences tests ER-100, a gene therapy that aims to restore vision by rejuvenating damaged retinal neurons.

Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...

How does origami-like DNA affect brain development? How do cancer-immune cell interactions prevent immune cell activity in tumors?Two breakthrough ...

In Alzheimer’s disease and other dementias, a protein called tau can pile up inside brain cells and form toxic clumps. Those ...

Studies have shown that in ALS patients, microtubules—which are the major component of the cell cytoskeleton and serve as tracks for transporting components from cell bodies to neuronal ...

I still vividly remember the first time we observed neurons responding not to audible sound, but to concentrated, precisely ...

Immunotherapy that blocks microglial Fcγ receptors prevents dopaminergic neuron loss in Parkinson’s disease, revealing a potential new strategy.

Arteries can narrow with fatty buildup. Blood struggles to move. Oxygen drops. A heart attack can follow, and it remains the ...